Proto-oncogenic H-Ras, K-Ras, and N-Ras are involved in muscle differentiation via phosphatidylinositol 3-kinase

Cell Research

Volumn 20, Issue 8, 2010, Pages 919-934

  Lee, Jisun ^a   Choi, Kyu Jin ^b   Lim, Min Jin ^a   Hong, Feng ^a   Choi, Tae Gyu ^a   Tak, Eunyoung ^a   Lee, Seonmin ^a   Kim, Young Joo ^c   Chang, Sung Goo ^a   Cho, Jin Man ^d   Ha, Joohun ^a   Kim, Sung Soo ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c Jeju National University School of Medicine   (South Korea)

^d Kyung Hee University College of Medicine   (South Korea)

Author keywords

c Ras; muscle differentiation; PI3K

Indexed keywords

CYBB PROTEIN, RAT; DRUG DERIVATIVE; FARNESOL; FARNESYLTHIOSALICYLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MEMBRANE PROTEIN; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P21; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SALICYLIC ACID DERIVATIVE; SMALL INTERFERING RNA; SALIRASIB;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; GENETICS; HEART MUSCLE; METABOLISM; MUSCLE DEVELOPMENT; PHYSIOLOGY; RAT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL DIFFERENTIATION; CELL LINE; FARNESOL; MEMBRANE GLYCOPROTEINS; MUSCLE DEVELOPMENT; MYOCARDIUM; NADPH OXIDASE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SALICYLIC ACIDS; SIGNAL TRANSDUCTION; PHOSPHATIDYLINOSITOL 3-KINASES; SALICYLATES;

EID: 77955282027     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.92     Document Type: Article

References (55)

1. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer 2003; 3:459-465.
2. Crespo P, Leon J. Ras proteins in the control of the cell cycle and cell differentiation. Cell Mol Life Sci 2000; 57:1613-1636.
3. Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Understanding 'Ras: 'it ain't over 'til it's over'. Trends Cell Biol 2000; 10:147-154.
4. Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 2002; 12:9-18.
5. Hancock JF. Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol 2003; 4:373-384.
6. Lowy DR, Willumsen BM. Function and regulation of ras. Annu Rev Biochem 1993; 62:851-891.
7. Nakamura K, Ichise H, Nakao K, et al. Partial functional overlap of the three ras genes in mouse embryonic development. Oncogene 2008; 27:2961-2968.
8. Prior IA, Harding A, Yan J, Sluimer J, Parton RG, Hancock JF. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat Cell Biol 2001; 3:368-375.
9. Rocks O, Peyker A, Kahms M, et al. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 2005; 307:1746-1752.
10. Apolloni A, Prior IA, Lindsay M, Parton RG, Hancock JF. Hras but not K-ras traffics to the plasma membrane through the exocytic pathway. Mol Cell Biol 2000; 20:2475-2487.
11. Matallanas D, Arozarena I, Berciano MT, et al. Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization. J Biol Chem 2003; 278:4572-4581.
12. Lim MJ, Choi KJ, Ding Y, et al. RhoA/Rho kinase blocks muscle differentiation via serine phosphorylation of insulin receptor substrate-1 and -2. Mol Endocrinol 2007; 21:2282-2293.
13. Faenza I, Ramazzotti G, Bavelloni A, et al. Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter. Endocrinology 2007; 148:1108-1117.
14. Lee KH, Kim DG, Shin NY, et al. NF-kappaB-dependent expression of nitric oxide synthase is required for membrane fusion of chick embryonic myoblasts. Biochem J 1997; 324:237-242.
15. Piao YJ, Seo YH, Hong F, et al. Nox 2 stimulates muscle differentiation via NF-kappaB/iNOS pathway. Free Radic Biol Med 2005; 38:989-1001.
16. Lim MJ, Seo YH, Choi KJ, et al. Suppression of c-Src activity stimulates muscle differentiation via p38 MAPK activation. Arch Biochem Biophys 2007; 465:197-208.
17. Lassar AB, Thayer MJ, Overell RW, Weintraub H. Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1. Cell 1989; 58:659-667.
18. Weyman CM, Ramocki MB, Taparowsky EJ, Wolfman A. Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras. Oncogene 1997; 14:697-704.
19. Olson EN, Spizz G, Tainsky MA. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol Cell Biol 1987; 7:2104-2111.
20. Yokoyama T, Takano K, Yoshida A, et al. DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras-ERK pathway, is required for myogenic differentiation. J Cell Biol 2007; 177:781-793.
21. Sun H, King AJ, Diaz HB, Marshall MS. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak. Curr Biol 2000; 10:281-284.
22. Mitin N, Kudla AJ, Konieczny SF, Taparowsky EJ. Differential effects of Ras signaling through NFkappaB on skeletal myogenesis. Oncogene 2001; 20:1276-1286.
23. Conejo R, de AC, Benito M, Cuadrado A, Lorenzo M. Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38- MAPK pathway. Oncogene 2002; 21:3739-3753.
24. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 1997; 272:6653-6662.
25. Downward J. Signal transduction. Prelude to an anniversary for the RAS oncogene. Science 2006; 314:433-434.
26. Chun YK, Kim J, Kwon S, et al. Phosphatidylinositol 3-kinase stimulates muscle differentiation by activating p38 mitogen-activated protein kinase. Biochem Biophys Res Commun 2000; 276:502-507.
27. Ding Y, Choi KJ, Kim JH, et al. Endogenous hydrogen peroxide regulates glutathione redox via nuclear factor erythroid 2-related factor 2 downstream of phosphatidylinositol 3-kinase during muscle differentiation. Am J Pathol 2008; 172:1529-1541.
28. Hong F, Lee J, Song JW, et al. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J 2002; 16:1633-1635.
29. Patel RP, Moellering D, Murphy-Ullrich J, Jo H, Beckman JS, Darley-Usmar VM. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radic Biol Med 2000; 28:1780-1794.
30. Castellano E, Guerrero C, Nunez A, De Las RJ, Santos E. Serum-dependent transcriptional networks identify distinct functional roles for H-Ras and N-Ras during initial stages of the cell cycle. Genome Biol 2009; 10:R123.
31. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008; 9:517-531.
32. Scholz ME, Meissner JD, Scheibe RJ, et al. Different roles of H-ras for regulation of myosin heavy chain promoters in satellite cell-derived muscle cell culture during proliferation and differentiation. Am J Physiol Cell Physiol 2009; 297:C1012-C1018.
33. Zhang J, Lodish HF. Identification of K-ras as the major regulator for cytokine-dependent Akt activation in erythroid progenitors in vivo. Proc Natl Acad Sci USA 2005; 102:14605-14610.
34. Johnson L, Greenbaum D, Cichowski K, et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 1997; 11:2468-2481.
35. Plowman SJ, Williamson DJ, O'Sullivan MJ, et al. While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable. Mol Cell Biol 2003; 23:9245-9250.
36. Castellano E, De Las RJ, Guerrero C, Santos E. Transcriptional networks of knockout cell lines identify functional specificities of H-Ras and N-Ras: significant involvement of N-Ras in biotic and defense responses. Oncogene 2007; 26:917-933.
37. Wolfman JC, Wolfman A. Endogenous c-N-Ras provides a steady-state anti-apoptotic signal. J Biol Chem 2000; 275:19315-19323.
38. Rommel C, Clarke BA, Zimmermann S, et al. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 1999; 286:1738-1741.
39. Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 1999; 286:1741-1744.
40. Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M. Regulation of Raf-Akt Cross-talk. J Biol Chem 2002; 277:31099-31106.
41. Virtanen C, Paris J, Takahashi M. Identification and characterization of a novel gene, dapr, involved in skeletal muscle differentiation and protein kinase B signaling. J Biol Chem 2009; 284:1636-1643.
42. Reuther GW, Der CJ. The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr Opin Cell Biol 2000; 12:157-165.
43. Elion EA. Routing MAP kinase cascades. Science 1998; 281:1625-1626.
44. Menges CW, McCance DJ. Constitutive activation of the Raf- MAPK pathway causes negative feedback inhibition of Ras- PI3K-AKT and cellular arrest through the EphA2 receptor. Oncogene 2008; 27:2934-2940.
45. Rodriguez-Viciana P, Warne PH, Dhand R, et al. Phosphatidylinositol- 3-OH kinase as a direct target of Ras. Nature 1994; 370:527-532.
46. Sasaki AT, Chun C, Takeda K, Firtel RA. Localized Ras signaling at the leading edge regulates PI3K, cell polarity, and directional cell movement. J Cell Biol 2004; 167:505-518.
47. Suire S, Hawkins P, Stephens L. Activation of phosphoinositide 3-kinase gamma by Ras. Curr Biol 2002; 12:1068-1075.
48. Lambert JM, Lambert QT, Reuther GW, et al. Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism. Nat Cell Biol 2002; 4:621-625.
49. Rubio I, Wetzker R. A permissive function of phosphoinositide 3-kinase in Ras activation mediated by inhibition of GTPase-activating proteins. Curr Biol 2000; 10:1225-1228.
50. Hara K, Yonezawa K, Sakaue H, et al. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci USA 1994; 91:7415-7419.
51. Mucsi I, Skorecki KL, Goldberg HJ. Extracellular signalregulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-beta1 on gene expression. J Biol Chem 1996; 271:16567-16572. (Pubitemid 26239011)
52. Kodaki T, Woscholski R, Hallberg B, Rodriguez-Viciana P, Downward J, Parker PJ. The activation of phosphatidylinositol 3-kinase by Ras. Curr Biol 1994; 4:798-806.
53. Yip SC, El-Sibai M, Coniglio SJ, et al. The distinct roles of Ras and Rac in PI 3-kinase-dependent protrusion during EGFstimulated cell migration. J Cell Sci 2007; 120:3138-3146.
54. Bokoch GM, Diebold BA. Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood 2002; 100:2692-2696.
55. Choi KJ, Piao YJ, Lim MJ, et al. Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatininduced cell death. Cancer Res 2007; 67:3654-3662.